Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis

BACKGROUND: Atrial fibrillation (AF) is the most common clinical arrhythmia and a major cause of morbidity and mortality in clinical practice. This study aims to determine the ranolazine for prevention and treatment of atrial fibrillation. METHOD: This study adheres to the Preferred Reporting Items...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Chengdai, Luo, Wei, Ren, Xiaocao, Ya, Maxiao, Yan, Wenlong, Hui, Quanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078434/
https://www.ncbi.nlm.nih.gov/pubmed/33879675
http://dx.doi.org/10.1097/MD.0000000000025437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078434/
https://www.ncbi.nlm.nih.gov/pubmed/33879675
http://dx.doi.org/10.1097/MD.0000000000025437

Ejemplares similares